Frontiers in Nutrition (May 2024)
Trends in urine lead and associated mortality in US adults: NHANES 1999–2018
Abstract
ObjectivesThis study aimed to describe the trends of urine lead among US adults aged ≥45 years and to explore its association with all-cause and disease-specific mortality.MethodsThis study enrolled 9,669 participants from the National Health and Nutrition Examination Survey, 1999–2018. Trends in urine lead were described by logistic regression analysis using the survey cycle as a continuous variable. Cox proportional hazard regression analyses were used to quantify the association between urine lead and mortality.ResultsThere was an obvious decline in urine lead concentrations from 1.203 μg/L (95% confidence interval [CI]: 1.083–1.322) in 1999–2000 to 0.478 μg/L (95% CI: 0.433–0.523) in 2017–2018, and this decline was statistically significant (P < 0.001). Referring to the first tertile of urine lead concentrations, risk magnitude for all-cause mortality was significantly and linearly increased after adjustment (P = 0.026 and 0.020 for partially and fully adjusted models, respectively), and significance was attained for the comparison of the third vs. first tertile after full adjustment (hazard ratio [HR]: 1.17, 95% CI: 1.01 to 1.35). Treating urine lead continuously, the risk for all-cause mortality was statistically significant (HR: 1.18 and 1.19, 95% CI: 1.01 to 1.39 and 1.00 to 1.40 for partially and fully adjusted models). For cardiovascular disease-specific and cancer-specific mortality, there was no hint of statistical significance.ConclusionsOur findings indicated that urine lead exhibited a declining trend from 1999–2000 to 2017–2018 in US adults aged ≥45 years, and high urine lead was a significant and independent risk factor for all-cause mortality.
Keywords
